The SIRPα/CD47 immune checkpoint is an essential mechanism for maintaining immunotolerance and protecting healthy cells. Check out this video to learn about this checkpoint, its challenges, and its potential as an attractive target for cancer immunotherapy.
Learn more about our bioassay for developing biologics that target SIRPα/CD47 interactions here: bit.ly/45J6zxd
25 май 2023